Drugs@FDA application record, NDA 020449 (TAXOTERE, docetaxel injection) (1996)

Government Record · U.S. Food and Drug Administration, Center for Drug Evaluation and Research · May 14, 1996

U.S. Food et al., 1996-05-14: FDA application record for Taxotere showing an original approval dated 14 May 1996 and Sanofi Aventis US as holder.

05/14/1996

HTML record, unpaginated

U.S. Food et al., 1996-05-14: FDA application record for Taxotere showing an original approval dated 14 May 1996 and Sanofi Aventis US as holder. Funder/conflicts: n/a. Maker: Sanofi (Rhone-Poulenc group). Comparator: n/a. FDA's Orange Book patent file for NDA 020449 contained no unexpired patents at retrieval; the first docetaxel ANDA (204193, Dr. Reddy's) is recorded by FDA as approved 5 November 2014, about 18 years after the NDA. Patent history: US 4,814,470 (CHI-22). Study type: regulatory record.